김은미 (서울대학교 약학대학)님 | 한빛사연구자 > 한빛사

서울대학교 약학대학

최종업데이트 2023.01.19.

Differential ligand binding/trafficking for distinct CTLA-4 fates: is it an expandable mechanism?
- Cell. Mol. Immunol., 2023 Jan;20(1):1-2 | doi: 10.1038/s41423-022-00945-3
- 2023-01
- 의약학
- 한빛사논문
Liver-originated small extracellular vesicles with TM4SF5 target brown adipose tissue for homeostatic glucose clearance
- J. Extracell. Vesicles, Volume11, Issue9 September 2022 e12262 | https://doi.org/10.1002/jev2.12262
- 2022-09
- 의약학
- 한빛사논문
TM4SF5-dependent crosstalk between hepatocytes and macrophages to reprogram the inflammatory environment
- Cell Reports, VOLUME 37, ISSUE 7, 110018, NOVEMBER 16, 2021 | https://doi.org/10.1016/j.celrep.2021.110018
- 2021-11
- 의약학
- 한빛사논문
N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application
- Theranostics, Published 2021-7-6, 11(16):8092-8111 | doi:10.7150/thno.58739
- 2021-07
- 의약학
- 한빛사논문

연구자 ID

저자논문